Spitzweg C, Reincke M, Gärtner R
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland.
Internist (Berl). 2017 Oct;58(10):1011-1019. doi: 10.1007/s00108-017-0306-0.
Thyroid emergencies are rare life-threatening endocrine conditions resulting from either decompensated thyrotoxicosis (thyroid storm) or severe thyroid hormone deficiency (myxedema coma). Both conditions develop out of a long-standing undiagnosed or untreated hyper- or hypothyroidism, respectively, precipitated by an acute stress-associated event, such as infection, trauma, or surgery. Cardinal features of thyroid storm are myasthenia, cardiovascular symptoms, in particular tachycardia, as well as hyperthermia and central nervous system dysfunction. The diagnosis is made based on clinical criteria only as thyroid hormone measurements do not differentiate between thyroid storm and uncomplicated hyperthyroidism. In addition to critical care measures therapy focusses on inhibition of thyroid hormone synthesis and secretion (antithyroid drugs, perchlorate, Lugol's solution, cholestyramine, thyroidectomy) as well as inhibition of thyroid hormone effects in the periphery (β-blocker, glucocorticoids).Cardinal symptoms of myxedema coma are hypothermia, decreased mental status, and hypoventilation with risk of pneumonia and hyponatremia. The diagnosis is also purely based on clinical criteria as measurements of thyroid hormone levels do not differ between uncomplicated severe hypothyroidism and myxedema coma. In addition to substitution of thyroid hormones and glucocorticoids, therapy focusses on critical care measures to treat hypoventilation and hypercapnia, correction of hyponatremia and hypothermia.Survival of both thyroid emergencies can only be optimized by early diagnosis based on clinical criteria and prompt initiation of multimodal therapy including supportive measures and treatment of the precipitating event.
甲状腺急症是罕见的危及生命的内分泌疾病,由失代偿性甲状腺毒症(甲状腺危象)或严重甲状腺激素缺乏(黏液性水肿昏迷)引起。这两种情况分别由长期未诊断或未治疗的甲状腺功能亢进或减退发展而来,由急性应激相关事件诱发,如感染、创伤或手术。甲状腺危象的主要特征是肌无力、心血管症状,尤其是心动过速,以及高热和中枢神经系统功能障碍。诊断仅基于临床标准,因为甲状腺激素测量无法区分甲状腺危象和单纯性甲状腺功能亢进。除了重症监护措施外,治疗重点是抑制甲状腺激素的合成和分泌(抗甲状腺药物、高氯酸盐、卢戈氏溶液、消胆胺、甲状腺切除术)以及抑制外周甲状腺激素的作用(β受体阻滞剂、糖皮质激素)。黏液性水肿昏迷的主要症状是体温过低、精神状态下降、通气不足,有发生肺炎和低钠血症的风险。诊断同样完全基于临床标准,因为甲状腺激素水平测量在单纯性严重甲状腺功能减退和黏液性水肿昏迷之间并无差异。除了补充甲状腺激素和糖皮质激素外,治疗重点是采取重症监护措施治疗通气不足和高碳酸血症,纠正低钠血症和体温过低。只有通过基于临床标准的早期诊断以及迅速启动包括支持措施和治疗诱发事件在内的多模式治疗,才能优化这两种甲状腺急症的生存率。